BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
Keyword: Regorafenib
1
Efficacy of regorafenib in the treatment of advanced hepatocellular carcinoma: A systematic review and meta-analysis
1/12/2026 10:07:38 AM | Browse: 62 | Download: 217
2
Efficacy comparison of fruquintinib, regorafenib monotherapy or plus programmed death-1 inhibitors for microsatellite stable metastatic colorectal cancer
6/15/2024 2:49:02 AM | Browse: 144 | Download: 640
3
Second-line therapy for advanced hepatocellular carcinoma with regorafenib or cabozantinib: Multicenter French clinical experience in real-life after matching
8/10/2022 1:14:37 PM | Browse: 586 | Download: 1956
4
Regorafenib combined with programmed cell death-1 inhibitor against refractory colorectal cancer and the platelet-to-lymphocyte ratio’s prediction on effectiveness
4/15/2022 9:40:09 AM | Browse: 656 | Download: 1885
5
Targeted agents for second-line treatment of advanced hepatocellular carcinoma
10/16/2019 12:17:24 PM | Browse: 940 | Download: 1577
6
Pharmacogenetics of the systemic treatment in advanced hepatocellular carcinoma
8/7/2019 7:09:17 AM | Browse: 1222 | Download: 2108
7
Targeted therapy or immunotherapy? Optimal treatment in hepatocellular carcinoma
5/15/2018 7:28:22 AM | Browse: 1457 | Download: 1909
8
Role of targeted therapy in metastatic colorectal cancer
9/12/2016 10:43:00 AM | Browse: 1301 | Download: 2298
9
Last line therapy with sorafenib in colorectal cancer: A retrospective analysis
6/13/2016 9:14:00 AM | Browse: 1430 | Download: 2829
10
New active drugs for the treatment of advanced colorectal cancer
12/24/2015 8:55:00 AM | Browse: 1157 | Download: 2106
11
Chemotherapy and target therapy for hepatocellular carcinoma: New advances and challenges
4/19/2015 5:46:00 PM | Browse: 1393 | Download: 2089
12
Advances and new perspectives in the treatment of metastatic colon cancer
8/26/2014 4:37:00 PM | Browse: 1469 | Download: 1844
Write to the Help Desk
© 1993-2026 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

California Corporate Number: 3537345